Atropine Sulfate injection

[Specification] 0.5mg/ml

[Indications] Atropine sulfate injection is indicated as a preoperative antimuscarinic agent to reduce salivary and bronchial secretions, for the treatment of symptomatic bradycardia and certain cardiac arrhythmias, for the treatment of organophosphate poisoning together with pralidoxime, and for the reversal of cholinergic effects during anaesthesia.

[Usage and dosage] Administer by intravenous, intramuscular, or subcutaneous injection according to the indication. For bradycardia, the usual adult dose is 0.5 mg, which may be repeated, with a total of up to 3 mg; the preoperative dose is 0.4 to 0.6 mg. In organophosphate poisoning, much larger doses are used, starting with 1 to 2 mg repeated every 5 to 10 minutes and titrated to effect under medical supervision